Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck shares rise after hours on priority review lung cancer drug application
Merck shares rise after hours on priority review lung cancer drug application
Merck shares rise after hours on priority review lung cancer drug application
Submitted by
admin
on January 11, 2017 - 10:11am
Source:
Marketwatch
News Tags:
Merck
Keytruda
lung cancer
priority review
FDA
Headline:
Merck shares rise after hours on priority review lung cancer drug application
Do Not Allow Advertisers to Use My Personal information
